glp-1 drugs mounjaro World Health Organization issues first-ever guidelines for use of weight loss medications GLP-1 Medications for Weight Loss

Lippincott Williams & Wilkins, Philadelphia, PA, USA Krishnan A, Hadi Y, Alqahtani SA et al (2023) Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity

CONTRAINDICATIONS : History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema

This is the most serious warning from the Food and Drug Administration (FDA)

We prioritize optimizing the bodys foundational systems and its natural ability to regulate appetite, metabolism, and GLP-1 signaling before considering prescription medications

A global federated real-world data and analytics platform for research

GLP-1 medication works best as part of a complete clinical program